Suppr超能文献

基于网络药理学和非靶向代谢组学探讨细辛肝损伤机制

[Discussion on hepatic damage mechanism of Asari Radix et Rhizoma based on network pharmacology and untargeted metabolomics].

作者信息

Bao Hui-Zhong, Zhu Li-Juan, Liu Xue-Feng, Wang Li-Juan, Luo Hui-Ying

机构信息

College of Pharmacy, Gansu University of Chinese Medicine Lanzhou 730101, China.

College of Pharmacy, Gansu University of Chinese Medicine Lanzhou 730101, China Key Laboratory of Pharmacology and Toxicology for Traditional Chinese Medicine of Gansu Province Lanzhou 730000, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2024 May;49(10):2575-2584. doi: 10.19540/j.cnki.cjcmm.20231107.401.

Abstract

Asari Radix et Rhizoma is a common drug for relieving exterior syndrome in clinics, but its toxicity limits its use. In this study, the mechanism of hepatic damage of Asari Radix et Rhizoma was studied by network pharmacology and metabolomics. The hepatic damage-related dataset, namely GSE54257 was downloaded from the GEO database. The Limma package was used to analyze the differentially expressed genes in the dataset GSE54257. Toxic components and target genes of Asari Radix et Rhizoma were screened by TCMSP, ECTM, and TOXNET. The hepatic damage target genes of Asari Radix et Rhizoma were obtained by mapping with the differentially expressed gene of GSE54257, and a PPI network was constructed. GO and KEGG enrichment analysis of target genes were performed, and a "miRNA-target gene-signal pathway" network was drawn with upstream miRNA information. Thirty rats were divided into a blank group, a high-dose Asari Radix et Rhizoma group, and a low-dose Asari Radix et Rhizoma group, which were administered once a day. After continuous administration for 28 days, liver function indexes and liver pathological changes were detected. Five liver tissue samples were randomly collected from the blank group and high-dose Asari Radix et Rhizoma group, and small molecule metabolites were analyzed by ultra-high performance liquid chromatography-mass spectrometry(UHPLC-MS). The orthogonal partial least squares-discriminant analysis(OPLS-DA) method was used to screen differential metabolites, and enrichment analysis, correlation analysis, and cluster analysis were conducted for differential metabolites. Finally, the MetaboAnalyst platform was used to conduct pathway enrichment analysis for differential metabolites. It was found that there were 14 toxic components in Asari Radix et Rhizoma, corresponding to 37 target genes, and 12 genes related to liver toxicity of Asari Radix et Rhizoma were obtained by mapping to differentially expressed genes of GSE54257. The animal test results showed that Asari Radix et Rhizoma could significantly increase the liver function index, reduce the activity of the free radical scavenging enzyme, change the liver oxidative stress level, and induce lipid peroxidation damage in rats. The results of untargeted metabolomics analysis showed that compared with the blank group, nine metabolites were up-regulated, and 16 metabolites were down-regulated in the liver tissue of the Asari Radix et Rhizoma group. These 25 metabolites had strong correlations and good clustering. Pathway enrichment analysis showed that these differential metabolites and the 12 hepatotoxic target genes of Asari Radix et Rhizoma were mainly involved in purine metabolism, as well as the biosynthesis and metabolism of valine, leucine, glycine, serine, and threonine. The study confirmed that the hepatica damage effect of Asari Radix et Rhizoma was the result of multi-component, multi-target, and multi-signaling pathways, and its mechanism may be related to inhibiting nucleotide synthesis and affecting protein metabolism.

摘要

细辛是临床常用的解表药,但因其毒性限制了其应用。本研究采用网络药理学和代谢组学方法研究细辛肝损伤的机制。从GEO数据库下载肝损伤相关数据集GSE54257。使用Limma软件包分析数据集GSE54257中的差异表达基因。通过中药系统药理学数据库与分析平台(TCMSP)、中药成分靶点数据库(ECTM)和毒理学网络数据库(TOXNET)筛选细辛的毒性成分和靶基因。将筛选出的细辛靶基因与GSE54257的差异表达基因进行映射,得到细辛肝损伤靶基因,并构建蛋白质-蛋白质相互作用(PPI)网络。对靶基因进行基因本体(GO)和京都基因与基因组百科全书(KEGG)富集分析,并结合上游微小RNA(miRNA)信息绘制“miRNA-靶基因-信号通路”网络。将30只大鼠分为空白组、高剂量细辛组和低剂量细辛组,每天给药1次。连续给药28天后,检测肝功能指标和肝脏病理变化。从空白组和高剂量细辛组中随机采集5份肝组织样本,采用超高效液相色谱-质谱联用(UHPLC-MS)技术分析小分子代谢物。采用正交偏最小二乘法判别分析(OPLS-DA)方法筛选差异代谢物,并对差异代谢物进行富集分析、相关性分析和聚类分析。最后,利用MetaboAnalyst平台对差异代谢物进行通路富集分析。结果发现,细辛含有14种毒性成分,对应37个靶基因,通过与GSE54257差异表达基因映射得到12个与细辛肝毒性相关的基因。动物实验结果表明,细辛可显著升高肝功能指标,降低自由基清除酶活性,改变肝脏氧化应激水平,诱导大鼠脂质过氧化损伤。非靶向代谢组学分析结果显示,与空白组相比,细辛组肝组织中有9种代谢物上调,16种代谢物下调。这25种代谢物具有较强的相关性和良好的聚类性。通路富集分析表明,这些差异代谢物和细辛的12个肝毒性靶基因主要参与嘌呤代谢以及缬氨酸、亮氨酸、甘氨酸、丝氨酸和苏氨酸的生物合成与代谢。该研究证实,细辛的肝损伤作用是多成分、多靶点、多信号通路作用的结果,其机制可能与抑制核苷酸合成和影响蛋白质代谢有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验